Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 8/20 | 0.45 |
| ▸ | CTSB | P07858 | 3/20 | 0.45 |
| ▸ | REN | P00797 | 5/20 | 0.43 |
| ▸ | F13A1 | P00488 | 1/20 | 0.41 |
| ▸ | TGM2 | P21980 | 1/20 | 0.41 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.41 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.41 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.41 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30963662 | 0.84 | POLB (0.51) | XIAP | |
| SCHEMBL31500753 | 0.84 | CTRB1 (0.47) | — | |
| SCHEMBL15216177 | 0.82 | POLB (0.48) | CTSBXIAP | |
| SCHEMBL22804000 | 0.82 | POLB (0.48) | CTSBXIAP | |
| SCHEMBL20210374 | 0.82 | POLB (0.48) | CTSBXIAP | |
| SCHEMBL29350646 | 0.82 | POLB (0.48) | CTSBXIAP | |
| SCHEMBL31321048 | 0.81 | REN (0.45) | CTSBRENF13A1TGM2NTSR2 | |
| SCHEMBL30963663 | 0.79 | XIAP (0.49) | XIAP | |
| SCHEMBL24579345 | 0.79 | ACE (0.49) | REN | |
| SCHEMBL31338976 | 0.79 | REN (0.40) | RENNTSR2NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350469-B | Method for synthesizing CAGRILINTIDE by large fragment SPPS-LPPS mixing method | 杭州诺澳生物医药科技有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-119350469-A | Method for synthesizing CAGRILINTIDE by large fragment SPPS-LPPS mixing method | 杭州诺澳生物医药科技有限公司 | 2025-01-24 | — | — | CN | disclosed |